ECTRIMS 2017 DAILY REPORT – THURSDAY EDITION

 

Friday Edition
Saturday Edition

Oral DMT use
Disease reactivation and miscarriage
French Canadians
Biomarkers
Concussion and MS


Increasing use of oral DMTs
A retrospective study obtained health administrative data to analyse the use of oral disease-modifying therapies in British Columbia, Canada, for the period 2011-2015 (Setayeshgar et al. ECTRIMS 2017; abstract P346). The oral DMTs introduced during this period were fingolimod, dimethyl fumarate and teriflunomide.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page